


TherageniX Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at TherageniX
Anand Nandakumar
CEO & Co-founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Healthcare, Biologics, Orthopaedic, Gene Therapy, Tissue Regeneration, Bone, Bone Grafts, Tissue Repair, Atmp |
| Founded | 2022 |
| Employees | 1-10 |
About TherageniX
TherageniX is an early-stage biotechnology company pioneering the use of gene therapy for tissue regeneration. Initially, it aims to augment autologous bone grafts using its proprietary technology to promote regenerative capacity, improve functional outcomes, and reduce additional trauma at the donor site. Transplantation of autologous bone is still the gold standard bone repair strategy, with 4 million grafting procedures performed annually worldwide. However, many bone implants still fail due to rejection or infection or fail to provide satisfactory functionality and regeneration. TherageniX is uniquely positioned to address the growing needs of the global bone grafts and substitutes market. TherageniX, a healthcare start-up built by NLC—the European healthtech venture builder, licensed the technology from Dr James Dixon’s group at the University of Nottingham and was incorporated in 2022 with the support of Nottingham Technology Ventures Ltd.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
TherageniX has 1 employees across 1 departments.
Departments
Number of employees
TherageniX Tech Stack
Discover the technologies and tools that power TherageniX's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
JavaScript libraries
Databases
Programming languages
Analytics
Blogs
JavaScript libraries
JavaScript libraries
Video players
JavaScript libraries
WordPress themes
Frequently asked questions
4.8
40,000 users



